Andrew Carr
Andrew Carr
St Vincent's Hospital and University of New South Wales, Sydney
Verified email at
Cited by
Cited by
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
A Carr, K Samaras, S Burton, M Law, J Freund, DJ Chisholm, DA Cooper
Aids 12 (7), F51-F58, 1998
Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial
ME Hannah, WJ Hannah, SA Hewson, ED Hodnett, S Saigal, AR Willan
The Lancet 356 (9239), 1375-1383, 2000
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
A Carr, K Samaras, A Thorisdottir, GR Kaufmann, DJ Chisholm, ...
The Lancet 353 (9170), 2093-2099, 1999
Adverse effects of antiretroviral therapy
A Carr, DA Cooper
The Lancet 356 (9239), 1423-1430, 2000
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
Cardiovascular risk and body-fat abnormalities in HIV-infected adults
S Grinspoon, A Carr
New England Journal of Medicine 352 (1), 48-62, 2005
Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
A Carr, K Samaras, DJ Chisholm, DA Cooper
The Lancet 351 (9119), 1881-1883, 1998
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome
A Carr, J Miller, M Law, DA Cooper
Aids 14 (3), F25-F32, 2000
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease
SA Danner, A Carr, JM Leonard, LM Lehman, F Gudiol, J Gonzales, ...
New England Journal of Medicine 333 (23), 1528-1534, 1995
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
An objective case definition of lipodystrophy in HIV-infected adults: a case-control study
A Carr
The Lancet 361 (9359), 726-735, 2003
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel
M Schambelan, CA Benson, A Carr, JS Currier, MP Dubé, JG Gerber, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 31 (3), 257-275, 2002
Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission
T Zhu, N Wang, A Carr, DS Nam, R Moor-Jankowski, DA Cooper, DD Ho
Journal of virology 70 (5), 3098-3107, 1996
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy
JS Currier, JD Lundgren, A Carr, D Klein, CA Sabin, PE Sax, JT Schouten, ...
Circulation 118 (2), e29-e35, 2008
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III …
K Samaras, H Wand, M Law, S Emery, D Cooper, A Carr
Diabetes care 30 (1), 113-119, 2007
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
PWG Mallon, J Miller, DA Cooper, A Carr
Aids 17 (7), 971-979, 2003
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
A Carr, D Marriott, A Field, E Vasak, DA Cooper
The Lancet 351 (9098), 256-261, 1998
The system can't perform the operation now. Try again later.
Articles 1–20